Cancer of Rectum: Clinical Trials

1 trial for Cancer of Rectum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Cancer of Rectum: new trials by email Literature Review of Cancer of Rectum trials Research Report on Cancer of Rectum

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients
50.4 Gy to the tumor and elective volume, 62 Gy to the clinical tumor volume and 50.4 Gy to the elective volume, Capecitabine 825 mg/m2 twice daily on weekdays - Cancer of Rectum
Phase 3RecruitingVejle Hospital1622020-01-202026-01-08

Narrower conditions

Rectal Neoplasms (1)

Broader conditions

Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Rectal Diseases (1)

Interventions

Capecitabine (1)

Sponsors

Vejle Hospital (1)

Countries

Denmark (1)

Top investigators

Lars H Jensen, MD, PhD (1)